Does CBD show up on a saliva drug test? What France checks
Yes, a saliva test can come back positive after a CBD product. The THC saliva test used by French police must detect Δ⁹-THC from 15 ng per millilitre of saliva and ignores CBD, yet a full-spectrum product may legally contain up to 0.30% THC. A laboratory then confirms from 1 ng/ml, and French law sets no tolerance threshold for drivers.

- 01What tests look for: THC, never CBD
- 02Screening, then confirmation: what does the THC saliva test measure?
- 03Why a legal product can make you test positive
- 04How long does THC stay detectable in saliva?
- 05Behind the wheel: no tolerance threshold
- 06Roadside check: the steps, and when the counter-analysis is decided
- 07THC saliva self-tests: useful for information, worthless as proof
- 08At work and in competition
- 09Lowering the risk: what actually matters
- 10Frequently asked questions
Key takeaways
- No roadside or workplace test looks for CBD. They all target THC or its metabolite, THC-COOH.
- French saliva kits must detect THC from 15 ng per millilitre of saliva; the confirmation analysis goes down to 1 ng/ml.
- In a 2021 trial, 7 of 14 participants tested positive in urine after 4 weeks on an oil with 0.02% THC.
- Driving after drug use carries up to 3 years in prison and a €9,000 fine, whatever the amount.
- A counter-analysis must be reserved when the second saliva sample is taken, then requested within 5 days of being notified of the result.
- Only a product whose certificate shows Δ⁹-THC as not detected really lowers the risk.
What tests look for: THC, never CBD
French drug tests target Δ⁹-THC, the psychoactive molecule in cannabis, and THC-COOH, an inactive metabolite the liver produces when it breaks THC down. The roadside kit screens for four drug families: cannabinoids, amphetamines, cocaine and opiates. For cannabinoids, the decree targets only THC and its metabolite: cannabidiol does not appear in it, and the French Highway Code sets no CBD threshold.
The cut-offs come from the decree (arrêté) of 13 December 2016 on drug testing of drivers. Each one is a detection limit, the level at which the test must react. None of them is a tolerance limit.
| Step | Sample | Molecule tested | Detection cut-off set by the decree |
|---|---|---|---|
| Roadside screening | Saliva | THC | 15 ng/ml of saliva |
| Urine screening (cases provided for in the text) | Urine | THC-COOH | 50 ng/ml of urine |
| Confirmation analysis | Saliva | THC | 1 ng/ml of saliva |
| Confirmation analysis | Blood | THC | 0.5 ng/ml of blood |
Screening, then confirmation: what does the THC saliva test measure?
The roadside kit is a rapid test: the decree requires it to detect THC from 15 ng/ml of saliva, and it does not measure how much. The offence of driving after drug use (article L235-1) is only established by the laboratory analysis, done by chromatography coupled with mass spectrometry, which detects THC from 1 ng/ml of saliva, a cut-off fifteen times lower, or from 0.5 ng/ml of blood.
| Step | Method | What the result is worth | Text |
|---|---|---|---|
| Screening | Strip read on the spot | A screening result, which triggers the checks (L235-2) | Decree, art. 3 |
| Confirmation | Chromatography and mass spectrometry | The analysis the L235-1 offence requires | Decree, art. 9 and 10; Highway Code, L235-1 |
The Highway Code targets a driver for whom "it results from a blood or saliva analysis" that they used drugs: the kit alone is not enough. Since 20 August 2026, article L237-1 also punishes driving "having manifestly used" drugs with the same 3 years and €9,000, without requiring any analysis. The laboratory must keep samples at −20 °C for at least one year and undergo external quality control (decree, article 13).
Grenoble University Hospital analysed 3,051 confirmation samples from drivers who screened positive, collected between 2018 and 2021 (Willeman et al., 2023): 98.2% of kit positives for cannabis were confirmed, against 22.6% for amphetamines and 17.3% for opiates, and 22.3% of samples showed at least one disagreement between kit and laboratory, all substances combined. The study says nothing about drivers who screened negative, whose samples were not sent. Under controlled conditions, against an analysis at a 10 ng/ml cut-off, 5 to 10% of the two kits' results were false positives and 9 to 16% false negatives, and neither met the recommended 80% for sensitivity, specificity and accuracy all at once (2019 Australian study).
A negative screen therefore does not prove that no THC is present. And each sample answers its own question: according to Drogues Info Service, saliva and blood mostly point to recent use, urine to recent or older use, and hair to long-term use, covered in the hair test.
Why a legal product can make you test positive
The 0.30% threshold applies to the sale of hemp and has nothing to do with driving. A compliant full-spectrum product contains small but real amounts of THC: a flower at 0.25% THC carries 2.5 mg per gram. With frequent use, that THC eventually crosses the cut-offs above. Our article on the legal THC level explains the sales threshold.
A team at McLean Hospital, which is affiliated with Harvard, put numbers on this. Their study, published in 2021 in JAMA Psychiatry, followed 14 adults taking a full-spectrum hemp oil every day. Each took about 35 mg of CBD and 0.8 mg of THC daily, from an oil assayed at 0.02% THC. After four weeks, 7 of the 14 participants had a urine test positive for THC-COOH, with an oil holding fifteen times less THC than the French ceiling.
Taking CBD at the same time does not mask THC: in the Australian study cited above, the THC curve in saliva was the same with or without an equal amount of CBD. Drogues Info Service, the public drug information service run by Santé publique France, makes the same point in a 2025 note on CBD and saliva tests: a driver who tests positive after CBD took a product that contained THC.
Can CBD turn into THC in the body?
No, according to human data. The conversion seen in simulated gastric fluid has not been found in vivo, even after high oral doses of CBD (Nahler et al., 2017). French toxicologists consider that this conversion appears, under certain conditions, to be an analytical artefact, and point out that a CBD product with up to 0.3% THC, sometimes much more for products sold online, can make both screening and confirmation positive (Alvarez et al., Thérapie, 2023). In the body, the THC therefore comes from the product.
How long does THC stay detectable in saliva?
A few hours after one-off use, longer in a daily user, and no length of time guarantees a negative test. The window depends on how often you use, how the product is taken and above all on the test's cut-off: published studies find THC in saliva for a few hours to a little over three days, at laboratory cut-offs of 0.2 to 2 ng/ml.
The table of positivity windows published by Drogues Info Service (June 2025) gives these orders of magnitude:
- Saliva: 6 to 8 hours after occasional use, up to 24 hours with regular use, up to 8 days with heavy daily use.
- Blood: THC detectable 2 to 8 hours after occasional use, THC-COOH up to 72 hours; over a month with heavy use.
- Urine: 3 to 5 days after occasional use, 30 to 70 days with regular use.
The table calls occasional at least one use in the year, regular more than one use a week (10 or more in the month), daily one use every day, and heavy daily use several uses a day over a long period. These windows vary widely from one person to another.
| Study | People | Use | Cut-off | Result |
|---|---|---|---|---|
| Anizan, 2013 | 14 frequent, 10 occasional | One joint at 6.8% THC; same protocol, two collection devices | 0.5 ng/ml | All positive up to 13.5 h; median last detection beyond 30 h in frequent users, 27 h in occasional users |
| Newmeyer, 2014 | 14 frequent, 10 occasional | One joint at 6.8% THC; same protocol, two collection devices | 1 ng/ml | Median last detection at 28 h (frequent) and 21 h (occasional), over 30 h of follow-up |
| Lee, 2011 | 28 daily users | Monitored abstinence | 0.5 ng/ml | THC generally quantifiable for 48 h after admission; positives fell from 89.3% at admission to 17.9% at 48 h |
| Odell, 2015 | 21 dependent users | Withdrawal unit | Not published in the abstract | Positive up to 78 h after admission |
| Swortwood, 2017 | 11 frequent, 9 occasional | Smoked, vaporised or eaten | 0.2 ng/ml | Peak due to deposits in the mouth; frequent users positive longer, whatever the route |
| Vikingsson, 2025 | 10 per dose | CBD oil with traces of THC | 2 ng/ml | Positive: 1 in 10 at 0.5 mg of THC per dose, 8 in 10 at 2.8 or 3.7 mg |
These cut-offs of 0.2 to 2 ng/ml (1 µg/l equals 1 ng/ml) are laboratory cut-offs, and none of these windows holds for a given person: Drogues Info Service points out that no method can predict precisely how long a test stays positive, as it depends on many factors.
No official source publishes a window specific to CBD products, and the test does not look for CBD itself. How long CBD stays in the body and the 2025 trial are covered in how long CBD stays in the body, and the detection-window tool gives an order of magnitude, with no guarantee. No waiting time guarantees a negative test: do not drive after a product that contains THC.
Behind the wheel: no tolerance threshold
Article L235-1 of the French Highway Code punishes driving after drug use with 3 years in prison and a €9,000 fine, penalties raised by the law of 9 July 2025, and with 5 years and €15,000 when alcohol is also involved. The offence also costs 6 licence points and can lead to a licence suspension of up to 5 years, according to the « Drogue au volant » page on service-public.fr.
The law sets no minimum amount. The Court of Cassation confirmed this on 21 June 2023 (appeal no. 22-85.530): the authorisation to sell hemp derivatives below 0.30% THC "has no bearing on the offence of driving after drug use". Having bought a legal product is therefore not a defence. The penalties are detailed in CBD and driving: what the law of 9 July 2025 tightens.
Roadside check: the steps, and when the counter-analysis is decided
If the kit is positive, a second saliva sample goes to a laboratory. That is the moment to say you want to reserve a counter-analysis (contre-expertise): a blood sample is then taken. The request itself is filed later, within 5 days of being notified of the result.
Screening is mandatory after an accident causing death or injury, possible after an accident with material damage only, a presumed traffic offence or a plausible reason to suspect drug use, and even with no reason at all, on the prosecutor's requisition or on the initiative of judicial police officers (article L235-2). The check then runs in this order:
- The kit, whose result shows within a few minutes, according to Drogues Info Service. If it is negative, the check ends there.
- If it is positive, you collect a second saliva sample yourself, under the supervision of a judicial police officer (decree, art. 7).
- The officer asks whether you want to reserve a counter-analysis or a search for psychoactive medicines. If you say yes, a doctor, nurse or biologist called in takes a blood sample as soon as possible, and a doctor carries out a clinical examination (article R235-6).
- The laboratory analyses the sample and keeps a tube of blood for a possible counter-analysis (article R235-9).
- Within 5 days of being notified of the results, you ask for the counter-analysis from the prosecutor, the investigating judge or the court named on the notification; a different laboratory carries it out. After a saliva analysis, it requires the reservation made at step 3 (article R235-11).
Refusing the checks is a separate offence, punished by 3 years in prison, a €9,000 fine and the loss of 6 points (article L235-3). Refusing the kit stops nothing: a saliva or blood sample is then taken.
In 2022, 776,000 drug screenings, 19% more than in 2021, led to 127,000 offences, according to a French Senate report. For a police check on foot, see police checks and CBD.
THC saliva self-tests: useful for information, worthless as proof
Cannabis screening tests are freely sold, in pharmacies as well as online, according to Drogues Info Service. Their result is only indicative and has no place in the Highway Code procedure; a negative self-test does not prove that no THC is present.
The leaflet gives the test's cut-off, the reading time and how to spot an invalid test. Whatever that cut-off, a self-test does not predict a later check: THC levels in saliva change from hour to hour and kits err in both directions. A negative self-test therefore does not clear you to drive: after a product that contains THC, do not drive. It does not detect CBD and says nothing about a product's THC content.
At work and in competition
An employer cannot test just anyone. Workplace saliva testing is limited to jobs where a mistake endangers the employee or others, and it must be provided for in the company's internal rules. The exact conditions and employee rights are in what an employer can legally test.
Can you refuse a saliva test at work?
On the road, refusing the checks is an offence. At work, the Highway Code does not apply: the test must be provided for in the internal rules for a safety-sensitive job, and the consequences of a refusal, which are disciplinary, are assessed within that framework.
For athletes, the World Anti-Doping Agency removed CBD from its prohibited list in 2018. THC remains banned in competition above 150 ng/ml of urine. An athlete taking a full-spectrum oil faces the same risk as a driver; the full picture is in CBD and doping: the 2026 WADA list.
Lowering the risk: what actually matters
The risk differs across three product families:
| Product type | THC present | Drug-test risk |
|---|---|---|
| Full spectrum (flower, resin, full-spectrum oil) | Yes, up to 0.30% | Highest, especially with daily use |
| Broad spectrum | THC removed, sometimes traces | Lower, not zero |
| CBD isolate | Not detected if the isolate is properly purified | Lowest |
What reduces the risk:
- Read the Δ⁹-THC line on the batch certificate of analysis: "ND" (not detected) or "< LOQ" (below the limit of quantification) is not the same as "0.2%". Our guide to reading a certificate of analysis goes through each line, the laboratory page describes the measurement methods, and THC-free CBD oil explains what the label covers.
- If you drive or are tested at work, choose an isolate. What "99%" guarantees is explained in CBD isolate: what 99% means, and the formulation differences in full spectrum or isolate.
- Do not drive after using a product that contains THC: no waiting time guarantees a negative test.
What does not work: quick "detox" products, litres of water before a test, and a certificate kept in the glovebox. It shows good faith, but the court looks at the analysis. Common beliefs about clearing THC are reviewed in clearing THC: myths and facts.
If your cannabis use, or a relative's, worries you, Drogues Info Service answers on 0 800 23 13 13, from 8 am to 2 am, 7 days a week, anonymously and free of charge, and its useful addresses lead to youth consultation services (CJC) and addiction treatment centres (CSAPA).
Frequently asked questions
No. The kit and the laboratory analysis look for THC, and cannabidiol does not appear in the decree of 13 December 2016. A positive test after CBD comes from the THC in the product.
Yes, if the product is full spectrum. It contains up to 0.30% THC, and regular use can be enough for the saliva kit to come back positive.
Drogues Info Service gives 6 to 8 hours after occasional use, up to 24 hours with regular use and up to 8 days with heavy daily use. There is no official window, and no length of time guarantees a negative result.
The kit answers within a few minutes. If it is positive, the second sample goes to the laboratory and you are notified of the result later; the 5 days to request a counter-analysis run from that notification.
No. The offence of driving after drug use (article L235-1) requires drug use established by a saliva or blood analysis in a laboratory. Since 20 August 2026, a separate offence covers driving after manifest drug use, with no analysis required (article L237-1).
Say so when the second saliva sample is taken, which triggers a blood sample. The request is then filed within 5 days of the notification, with the magistrate or court it names.
The product's legality is not a defence: the Court of Cassation ruled so on 21 June 2023. You can challenge whether the procedure was lawful. You can also request a counter-analysis; after a saliva analysis, it is only admissible if you reserved it when the second sample was taken.
Yes, self-tests are sold there, as well as online. Their result is only indicative and does not predict a check: a negative self-test does not clear you to drive after a product that contains THC.
A properly purified isolate contains no detectable THC, and according to Drogues Info Service, CBD without THC does not trigger the test. Check that the batch certificate shows Δ⁹-THC as not detected.
In a trial published in 2025, CBD in saliva peaked half an hour after a dose of oil, then dropped quickly. The roadside check does not look for it.
Sources and update
Texts and studies checked on 20 October 2026, in the version in force that day.
- French Highway Code: L235-1 and L235-3, version of 20 August 2026; L237-1, created on 20 August 2026; L235-2, of 25 March 2019; R235-6, of 12 June 2024; R235-9, of 27 August 2016; R235-11, of 5 December 2019.
- Decree of 13 December 2016, unchanged since 16 December 2016; law no. 2025-622 of 9 July 2025; service-public.fr page F2886, checked on 27 August 2026; Drogues Info Service table, June 2025.
- Studies: Dahlgren 2021 (JAMA Psychiatry); Arkell 2019, Newmeyer 2014, Swortwood 2017 (Drug Testing and Analysis); Willeman 2023, Odell 2015 (Forensic Science International); Alvarez 2023 (Thérapie); Nahler 2017 (Cannabis and Cannabinoid Research); Anizan 2013 (Analytical and Bioanalytical Chemistry); Lee 2011 (Clinical Chemistry); Vikingsson 2025 (Journal of Analytical Toxicology).
Written by the Phytogrammes team
Each journal article draws on cited primary sources: ANSM, EFSA, EUR-Lex and peer-reviewed publications. Product profiles are distinguished from documented laboratory results. Our approach.
Article published on . CBD is not a medicine.